TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $454,000 | +4.8% | 31,697 | -0.2% | 0.17% | +5.7% |
| Q4 2021 | $433,000 | -16.7% | 31,767 | 0.0% | 0.16% | -25.8% |
| Q3 2021 | $520,000 | -2.8% | 31,767 | 0.0% | 0.21% | -2.7% |
| Q2 2021 | $535,000 | -12.3% | 31,767 | -4.9% | 0.22% | -19.5% |
| Q1 2021 | $610,000 | -9.2% | 33,408 | -9.5% | 0.27% | -15.8% |
| Q4 2020 | $672,000 | +2.1% | 36,931 | +0.2% | 0.32% | -10.0% |
| Q3 2020 | $658,000 | -0.5% | 36,861 | 0.0% | 0.36% | -6.3% |
| Q2 2020 | $661,000 | +18.0% | 36,861 | 0.0% | 0.38% | -3.5% |
| Q1 2020 | $560,000 | -23.0% | 36,861 | 0.0% | 0.40% | -0.8% |
| Q4 2019 | $727,000 | +14.1% | 36,861 | -0.5% | 0.40% | +6.4% |
| Q3 2019 | $637,000 | -3.2% | 37,029 | -0.4% | 0.38% | -6.0% |
| Q2 2019 | $658,000 | -13.2% | 37,196 | 0.0% | 0.40% | -15.3% |
| Q1 2019 | $758,000 | – | 37,196 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |